Wuhan YZY Biopharma Co Ltd
Status: Publicly traded
Direct answer
Wuhan YZY Biopharma Co Ltd is publicly traded on HKSE under the ticker 2496.HK.
Wuhan YZY Biopharma Co., Ltd., a biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related eye diseases. It develops various product candidates for the treatment of malignant ascites, malignant pleural effusion, solid tumors, pancreatic cancer, hepatocellular carcinoma and other advanced solid tumors, small cell lung cancer,...
Can you invest in Wuhan YZY Biopharma Co Ltd?
Yes. Wuhan YZY Biopharma Co Ltd is publicly traded on HKSE under the ticker 2496.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Wuhan YZY Biopharma Co Ltd
Detailed equity research is provided by MarketSnap.